186 related articles for article (PubMed ID: 35893105)
1. The Impact of Gleason Grade 3 as a Predictive Factor for Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group).
Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
Medicina (Kaunas); 2022 Jul; 58(8):. PubMed ID: 35893105
[No Abstract] [Full Text] [Related]
2. Short-term oncological and surgical outcomes of robot-assisted radical prostatectomy: A retrospective multicenter cohort study in Japan (the MSUG94 group).
Kato D; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
Asian J Endosc Surg; 2022 Oct; 15(4):745-752. PubMed ID: 35508895
[TBL] [Abstract][Full Text] [Related]
3. Clinical factors associated with biochemical recurrence of prostate cancer with seminal vesicle invasion followed by robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group).
Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
J Robot Surg; 2023 Aug; 17(4):1609-1617. PubMed ID: 36928750
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group).
Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
Ann Surg Oncol; 2024 Mar; 31(3):2154-2162. PubMed ID: 38200385
[TBL] [Abstract][Full Text] [Related]
5. Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patients.
Sugino F; Nakane K; Kawase M; Ueda S; Tomioka M; Takeuchi Y; Yamada T; Namiki S; Kumada N; Kawase K; Kato D; Takai M; Iinuma K; Tobisawa Y; Ito T; Koie T
J Robot Surg; 2023 Oct; 17(5):2441-2449. PubMed ID: 37466903
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
[TBL] [Abstract][Full Text] [Related]
7. Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up.
Rajan P; Hagman A; Sooriakumaran P; Nyberg T; Wallerstedt A; Adding C; Akre O; Carlsson S; Hosseini A; Olsson M; Egevad L; Wiklund F; Steineck G; Wiklund NP
Eur Urol Focus; 2018 Apr; 4(3):351-359. PubMed ID: 28753802
[TBL] [Abstract][Full Text] [Related]
8. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
[TBL] [Abstract][Full Text] [Related]
9. Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years.
Sooriakumaran P; Haendler L; Nyberg T; Gronberg H; Nilsson A; Carlsson S; Hosseini A; Adding C; Jonsson M; Ploumidis A; Egevad L; Steineck G; Wiklund P
Eur Urol; 2012 Nov; 62(5):768-74. PubMed ID: 22633365
[TBL] [Abstract][Full Text] [Related]
10. Preoperative prognostic factors for biochemical recurrence after robot-assisted radical prostatectomy in Japan.
Hashimoto T; Yoshioka K; Gondo T; Ozu C; Horiguchi Y; Namiki K; Ohno Y; Ohori M; Nakashima J; Tachibana M
Int J Clin Oncol; 2014 Aug; 19(4):702-7. PubMed ID: 24048883
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
12. Technical Refinements in Superextended Robot-assisted Radical Prostatectomy for Locally Advanced Prostate Cancer Patients at Multiparametric Magnetic Resonance Imaging.
Mazzone E; Dell'Oglio P; Rosiello G; Puliatti S; Brook N; Turri F; Larcher A; Beato S; Andras I; Wisz P; Pandey A; De Groote R; Schatteman P; De Naeyer G; D'Hondt F; Mottrie A
Eur Urol; 2021 Jul; 80(1):104-112. PubMed ID: 32943260
[TBL] [Abstract][Full Text] [Related]
13. The Negative Impact of Inflammation-Related Parameters in Prostate Cancer after Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (the MSUG94 Group).
Murase K; Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137801
[No Abstract] [Full Text] [Related]
14. Comparative analysis of oncologic outcomes for open vs. robot-assisted radical prostatectomy in high-risk prostate cancer.
Lee D; Choi SK; Park J; Shim M; Kim A; Lee S; Song C; Ahn H
Korean J Urol; 2015 Aug; 56(8):572-9. PubMed ID: 26279826
[TBL] [Abstract][Full Text] [Related]
15. Prognostic differences among the positive surgical margin locations following robot-assisted radical prostatectomy in a large Japanese cohort (the MSUG94 group).
Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kawase M; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
Jpn J Clin Oncol; 2023 Apr; 53(5):443-451. PubMed ID: 36708227
[TBL] [Abstract][Full Text] [Related]
16. Oncological outcomes after robot-assisted radical prostatectomy: long-term follow-up in 4803 patients.
Sukumar S; Rogers CG; Trinh QD; Sammon J; Sood A; Stricker H; Peabody JO; Menon M; Diaz-Insua M
BJU Int; 2014 Dec; 114(6):824-31. PubMed ID: 24053586
[TBL] [Abstract][Full Text] [Related]
17. Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.
Abdollah F; Dalela D; Sood A; Sammon J; Jeong W; Beyer B; Fossati N; Rogers CG; Diaz-Insua M; Peabody J; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
World J Urol; 2016 Oct; 34(10):1357-66. PubMed ID: 26873596
[TBL] [Abstract][Full Text] [Related]
18. The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical Prostatectomy.
Bravi CA; Dell'Oglio P; Mazzone E; Moschovas MC; Falagario U; Piazza P; Scarcella S; Bednarz C; Sarchi L; Tappero S; Knipper S; De Groote R; Sjoberg D; Schiavina R; Suardi N; Terrone C; Autorino R; Carrieri G; Galosi A; Galfano A; Briganti A; Montorsi F; Patel V; Vickers A; Mottrie A
Eur Urol Oncol; 2023 Aug; 6(4):414-421. PubMed ID: 35850976
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94).
Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kawase M; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
World J Urol; 2024 Mar; 42(1):152. PubMed ID: 38483586
[TBL] [Abstract][Full Text] [Related]
20. Clinical Factors Associated With Pathological Grade Group 1 Patients in D'Amico Intermediate-Risk Group Following Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group).
Sugino Y; Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kawase M; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
Clin Genitourin Cancer; 2022 Dec; 20(6):593-600. PubMed ID: 35773146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
